Manulife (Manufacturers Life Insurance)
HOWL icon

Manulife (Manufacturers Life Insurance)’s Werewolf Therapeutics HOWL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,831
Closed -$153 – 3120
2021
Q4 		$153 Buy
+12,831
New +$194K ﹤0.01% 2980

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HOWL Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Werewolf Therapeutics (HOWL) in Q1 2022, closing a stake of 12,831 shares — an estimated $153 sold.

Manulife (Manufacturers Life Insurance) first reported a position in HOWL in Q4 2021 and held it in 1 quarter. The position peaked at $153 in Q4 2021. 49 funds tracked by Wall St. Rank hold HOWL as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Werewolf Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 12,831 Werewolf Therapeutics shares in Q1 2022, an estimated $153.
  • Manulife (Manufacturers Life Insurance) first reported a position in Werewolf Therapeutics in Q4 2021 and held it in 1 quarter.
  • Manulife (Manufacturers Life Insurance)'s Werewolf Therapeutics position peaked at $153 in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.